Particle.news

Download on the App Store

Researchers Target ER ATP Transporter SLC35B1 for Therapeutic Development

The identification of SLC35B1 as the endoplasmic reticulum ATP transporter opens avenues for treating diseases linked to ER stress, with drug discovery efforts now underway.

Image
Content cover image
Image
Image

Overview

  • SLC35B1 has been confirmed as the protein responsible for transporting ATP into the endoplasmic reticulum, resolving a decades-old mystery in cellular bioenergetics.
  • High-resolution cryo-EM imaging revealed SLC35B1’s structure and step-wise mechanism, highlighting specific ATP-binding sites critical for its function.
  • A CRISPR/Cas9 screen ranked SLC35B1 among top transporters essential for cellular viability, consolidating its role in ER ATP transport.
  • Researchers are actively screening small-molecule libraries to identify compounds that modulate SLC35B1 activity, aiming to address ER stress-related conditions like diabetes, cancer, and neurodegeneration.
  • This breakthrough demonstrates the power of interdisciplinary research, combining structural biology, genomics, and biochemistry to tackle complex cellular challenges.